CTLA4 and neoplasm: When the tumor sizes reached approximately 70 mm3, the mice were intratumorally treated with the above RNA-loaded LNPs and controls for four times at 3-day intervals, accompanied by five doses of intraperitoneal anti-cytotoxic T-lymphocyte-associated protein 4 (αCTLA-4) treatment (Figure 4C).